The extension should be subject to certain conditions to ensure that only in vitro diagnostic medical devices that are safe and for which the manufacturers have taken certain steps to transition towards compliance with Regulation (EU) 2017/746 are to benefit from the additional transitional period.
Recital 12, Regulation (EU) 2024/1860
In forcesince 13 Jun 2024